HYFT
ImmunoPrecise Antibodies Ltd.
NASDAQ: HYFT · HEALTHCARE · BIOTECHNOLOGY
$1.19
+0.00% today
Updated 2026-04-30
Market cap
$54.19M
P/E ratio
—
P/S ratio
1.93x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$0 – $3
Volume
0.3M
ImmunoPrecise Antibodies Ltd. (HYFT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |